IDACIO 40 mg/0.8 ml, solution for injection for paediatric use bottle, 0.8 ml + 1 needle
Active ingredients: Adalimumab
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 0.8 ml + 1 needlesous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IDACIO 40 mg/0,8 ml, solution injectable pour usage pédiatrique
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon en verre de 0,8 ml + 1 seringue + 1 aiguille + 1 adaptateur pour flacon + 2 tampons d’alcool
- Marketing authorisation holder
- FRESENIUS KABI DEUTSCHLAND (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63592177CIP73017276CIP133400930172766Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ADALIMUMABsolution | 40 mg · un flacon de 0,8 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.